临床护理路径对首发精神分裂症患者服药依从性及复发的影响

On the Influence of Clinical Nursing Path on Schizophrenia Patients＇ Medication Adherence and Recurrence

目的：探讨临床护理路径对首发精神分裂症患者服药依从性及复发的影响。方法：将112例首发精神分裂症患者随机分为两组各56例，两组均进行系统的抗精神病药物治疗，对照组采用一般健康教育，实验组采用有计划性，针对性的临床护理路径管理，并于不同时间使用不同量表进行评定。结果：出院时，出院后1年、2年ITAQ评分，服药依从性及复发率两组比较差异有显著意义（P〈0．05）；BPRS评分出院时两组差异无显著意义（P〉0．05），出院后1年、2年两组比较，差异有显著性意义（P〈0．05）。结论：临床护理路径不仅能够提高首发精神分裂症患者服药依从性，而且能降低复发率。

Objective： To explore the influence of clinical nursing path on schizophrenia patients＇ medication adherence and recurrence. Methods： 112 schizophrenia patients were randomly divided into the experimental group and the control group; each group consisted of 56 patients. Both groups used antipsychotic therapy, and general health education was applied to the control group while the clinical nursing was applied to the experimental group. Use the Brief Psychiatric Rating Scale （BPRS）, Insight and Treatment Attitudes Questionnaire （ITAQ） and assessment of medication compliance to assess the results 1 year, 2 years after discharge, respectively. Results： For ITAQ score, medication adherence and recurrence of two groups were significantly different （P〈 0.05）. For BPRS score, the two groups showed no significant difference （P 〉 0.05） when patients left the hospital but significant difference （P 〈0.05） after they were discharged from hospital for 1 or 2 years. Conclusion： Clinical nursing path can not only improve medication compliance in patients, but also reduce the recurrence rate.